Brucellosis has been present for millennia and has managed to elude eradication, even in most developed countries. Brucellosis causes much clinical morbidity as well as an important loss of agricultural productivity in the developing world. In this era of international tourism, brucellosis has become a common imported disease in the developed world. This review article discusses the pathogenesis and treatment of the disease.

The authors provide evidence-based guidance on treating human brucellosis, and discuss the future clinical trials that would help address the controversies surrounding treatment.